Aug 27, 2014 at 22:08 | Source: Moneycontrol.com
Lifeline Drugs & Pharma has informed regarding Outcome of Board Meeting held on August 27, 2014.
Aug 27, 2014 at 13:43 | Source: Moneycontrol.com
Venus Remedies will be initially manufacturing the drug at the Venus Medicine Research Centre, its research unit, for assisting Teva in registrations.
Aug 26, 2014 at 20:23 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals board meeting will be held on September 04, 2014, to transact and review the performance of the Company. To take note of resignation of Independent Directors and consider appointment of Additional Directors to fill the vacancy.
Aug 26, 2014 at 15:25 | Source: Moneycontrol.com
According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high long-term growth, subject to timely regulatory approval.
Aug 26, 2014 at 14:17 | Source: Moneycontrol.com
Strides Arcolab has received approval from United State Food & Drug Administration for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg.
Aug 25, 2014 at 22:02 | Source: Moneycontrol.com
Lifeline Drugs & Pharma board meeting will be held on August 27, 2014, to consider and approve the Directors Report, Management Discussion Analysis Report and Report on Corporate Governance for the year ended March 31, 2014 and consider Appointment of Mr. Deepak Bansal as Joint Managing Director.
Aug 22, 2014 at 13:08 | Source: Moneycontrol.com
Kabra Drugs has reported a sales total income from operations of Rs 2.15 crore and a net profit of Rs 0.06 crore for the quarter ended Jun '14
Aug 20, 2014 at 15:35 | Source: PTI
"Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets," the company said in a statement issued today.
Aug 20, 2014 at 13:40 | Source: Moneycontrol.com
"Venus has achieved yet another landmark by receiving its first marketing authorisation in Switzerland from Swiss drug authority (SWISSMEDIC) for Gemcitabine 200 mg and 1 g injection through Venus Pharma GmbH, the German subsidiary," said the company in its filing.
Aug 20, 2014 at 13:39 | Source: Moneycontrol.com
Zydus Cadila has received the final approval from the USFDA to market Acyclovir tablets in the strenths of 400 mg and 800 mg.